The following tables summarize the components of the basic and diluted EPS computations (in thousands, except per share amounts):


	Three Months Ended June 30,					Six Months Ended June 30,
	2025		2024			2025		2024
EPS – basic:
Net income (loss) (numerator)	$	668	$	(2,014	)	$	13,826	$	8,616
Weighted average common shares (denominator)		304,954		273,056			304,222		271,706
Net income (loss) per share	$	0.00	$	(0.01	)	$	0.05	$	0.03
EPS – diluted:
Net income (loss) (numerator)	$	668	$	(2,014	)	$	13,826	$	8,616

Weighted average common shares		304,954		273,056			304,222		271,706
Effect of dilutive securities – common shares issuable		6,530		—			8,159		7,652
Adjusted weighted average common shares (denominator)		311,484		273,056			312,381		279,358
Net income (loss) per share	$	0.00	$	(0.01	)	$	0.04	$	0.03

For the three months ended June 30, 2025, diluted net income per share excluded the weighted average effect of 6.3 million shares of common stock underlying RSUs and Market and Performance RSUs, 1.0 million shares of common stock underlying options and PNQs and 7.0 million common shares issuable upon conversion of our senior convertible notes as they were antidilutive.

For the six months ended June 30, 2025, diluted net income per share excluded the weighted average effect of 3.3 million shares of common stock underlying RSUs and Market and Performance RSUs, 0.3 million shares of common stock underlying options and PNQs and 7.0 million common shares issuable upon conversion of our senior convertible notes as they were antidilutive.

For the three months ended June 30, 2024, diluted net income per share excluded the weighted average effect of 16.8 million shares of common stock underlying RSUs and Market and Performance RSUs, 7.9 million shares of common stock underlying options and PNQs and 44.1 million common shares issuable upon conversion of our senior convertible notes as they were antidilutive. Market RSUs issued in 2021, 2022 and 2023 are included at the share delivery of 194%, 178% and 100%, respectively, in accordance with a valuation assessment obtained as of June 30, 2024.

For the six months ended June 30, 2024, diluted net income per share excluded the weighted average effect of 7.8 million shares of common stock underlying RSUs and Market RSUs, 1.9 million shares of common stock underlying options and PNQs and 44.1 million common shares issuable upon conversion of our senior convertible notes as they were antidilutive.